Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Brought to you by:
Cell & Gene Therapy
Research
Ernexa's stem cell therapy shrinks ovarian tumors in mice
The cells were engineered to produce two proinflammatory cytokines, IL-7 and IL-15, which help T cells infiltrate and fight tumors.
Darren Incorvaia
Jun 2, 2025 2:30pm
ASCO: Kite's CAR-T flies high in phase 1 B-cell lymphoma study
May 31, 2025 7:00pm
ASCO: Immatics cell therapy sees 56% ORR in advanced melanoma
May 31, 2025 8:00am
Intellia stock sinks on gene therapy patient's raised enzymes
May 29, 2025 9:15am
Gene editing leaders call for 10-year ban on heritable edits
May 28, 2025 7:00am
Rocket crashes as gene therapy patient dies, FDA imposes hold
May 27, 2025 9:49am
More News
RegenXBio sells $250M of paydays for Zolgensma, other therapies
May 20, 2025 7:15am
CRISPR Tx, Sirius pen collab with a focus on thrombotic disease
May 20, 2025 3:59am
Gene editor shelves sole clinical asset, lays off 25% of staff
May 19, 2025 2:28pm
Atsena gene therapy hits safety goals, closes retinal splits
May 19, 2025 12:59pm
See more stories